DK1276896T3 - Epitop-synkronisering i antigen-præsenterende celler - Google Patents
Epitop-synkronisering i antigen-præsenterende cellerInfo
- Publication number
- DK1276896T3 DK1276896T3 DK01930922.8T DK01930922T DK1276896T3 DK 1276896 T3 DK1276896 T3 DK 1276896T3 DK 01930922 T DK01930922 T DK 01930922T DK 1276896 T3 DK1276896 T3 DK 1276896T3
- Authority
- DK
- Denmark
- Prior art keywords
- housekeeping
- disclosed
- antigen
- cells
- presenting cells
- Prior art date
Links
- 210000000612 antigen-presenting cell Anatomy 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 5
- 229960005486 vaccine Drugs 0.000 abstract 4
- 230000028993 immune response Effects 0.000 abstract 2
- 230000002093 peripheral effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 244000000056 intracellular parasite Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56046500A | 2000-04-28 | 2000-04-28 | |
US56157100A | 2000-04-28 | 2000-04-28 | |
US56157200A | 2000-04-28 | 2000-04-28 | |
US09/561,074 US6861234B1 (en) | 2000-04-28 | 2000-04-28 | Method of epitope discovery |
PCT/US2001/013806 WO2001082963A2 (en) | 2000-04-28 | 2001-04-27 | Method of identifying and producing antigen peptides and use thereof as vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1276896T3 true DK1276896T3 (da) | 2010-10-18 |
Family
ID=27504814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01930922.8T DK1276896T3 (da) | 2000-04-28 | 2001-04-27 | Epitop-synkronisering i antigen-præsenterende celler |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070269464A1 (da) |
EP (4) | EP2278023A1 (da) |
JP (1) | JP2003535824A (da) |
CN (1) | CN1440462A (da) |
AT (1) | ATE474931T1 (da) |
AU (3) | AU2001257410B8 (da) |
CA (1) | CA2405363A1 (da) |
DE (1) | DE60142615D1 (da) |
DK (1) | DK1276896T3 (da) |
ES (1) | ES2347762T3 (da) |
HK (1) | HK1053333A1 (da) |
NZ (1) | NZ521715A (da) |
WO (1) | WO2001082963A2 (da) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
US6977074B2 (en) | 1997-07-10 | 2005-12-20 | Mannkind Corporation | Method of inducing a CTL response |
US20030138808A1 (en) * | 1998-02-19 | 2003-07-24 | Simard John J.L. | Expression vectors encoding epitopes of target-associated antigens |
US20030215425A1 (en) * | 2001-12-07 | 2003-11-20 | Simard John J. L. | Epitope synchronization in antigen presenting cells |
US6773695B2 (en) * | 2000-10-05 | 2004-08-10 | Mannkind Corporation | Modulation of allergic response |
US7252824B2 (en) | 2001-03-07 | 2007-08-07 | Mannkind Corporation | Anti-neovasculature preparations for cancer |
EP1595548A3 (en) * | 2001-03-07 | 2006-02-22 | Mannkind Corporation | Anti-neovasculature preparations for treating cancer |
WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
EP1752160A3 (en) | 2001-04-06 | 2007-05-30 | Mannkind Corporation | Epitope sequences |
DE60238864D1 (de) * | 2001-11-07 | 2011-02-17 | Mankind Corp | Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption |
AU2008229888B2 (en) * | 2001-11-07 | 2012-07-05 | Mannkind Corporation | Expression vectors encoding epitopes of target-associated antigens and methods for their design |
MXPA05002455A (es) * | 2002-09-06 | 2005-06-03 | Mannkind Corp | Secuencias de epitopes. |
CN102370974B (zh) | 2002-12-16 | 2014-09-17 | 全球免疫股份有限公司 | 用于免疫治疗的基于酵母的疫苗 |
US8343502B2 (en) | 2002-12-16 | 2013-01-01 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
ATE496129T1 (de) * | 2003-07-22 | 2011-02-15 | Ludwig Inst Cancer Res | Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide |
CA2592968A1 (en) * | 2004-12-29 | 2006-07-06 | Mannkind Corporation | Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
SG158155A1 (en) * | 2004-12-29 | 2010-01-29 | Mannkind Corp | Methods to bypass cd+4 cells in the induction of an immune response |
SG162817A1 (en) | 2005-06-17 | 2010-07-29 | Mannkind Corp | Methods and compositions.to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
NZ564360A (en) * | 2005-06-17 | 2011-03-31 | Mannkind Corp | Immunogenic product comprising a nucleic acid capable of expressing a PRAME epitope and a PSMA epitope and a peptide composition |
AU2007222080B2 (en) * | 2006-03-01 | 2012-08-16 | Janssen Pharmaceutica N.V. | Cancer treatment combining lymphodepleting agent with CTLs and cytokines |
EP1996716B1 (en) | 2006-03-20 | 2011-05-11 | The Regents of the University of California | Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
JP2009544610A (ja) * | 2006-07-14 | 2009-12-17 | マンカインド コーポレイション | 予防又は治療目的のためにmhcクラスi拘束エピトープに対する免疫応答を引き出し、増強し、保持する方法 |
US9487574B2 (en) | 2006-09-21 | 2016-11-08 | Vaxil Biotherapeutics Ltd. | Antigen specific multi epitope vaccines |
CN101246176B (zh) * | 2007-02-13 | 2013-06-05 | 许洋 | 鳞状细胞癌抗原阴性宫颈癌血清蛋白质检测的质谱试剂及其制备方法 |
WO2009032949A2 (en) | 2007-09-04 | 2009-03-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
EP2398504B1 (en) | 2009-02-17 | 2018-11-28 | Cornell Research Foundation, Inc. | Methods and kits for diagnosis of cancer and prediction of therapeutic value |
MX354143B (es) | 2009-12-02 | 2018-02-14 | Imaginab Inc | Minicuerpos j591 y diacuerpos-cys para apuntar con especificidad de objetivo a un antígeno de membrana específico para próstata de humano (psma) y métodos para su uso. |
WO2012031076A1 (en) * | 2010-09-02 | 2012-03-08 | Ludwig Institute For Cancer Research, Ltd. | Recombinant trypanosoma cruzi cells useful as anti-cancer immune agents |
EP2714072A1 (en) * | 2011-05-26 | 2014-04-09 | Geneius Biotechnology Investments, LLC | Modulated immunodominance therapy |
EP3604634A1 (en) * | 2012-09-05 | 2020-02-05 | Arizona Board of Regents, a Body Corporate of the State of Arizona, acting for and on behalf of Arizona State University | Methods for discovering therapeutic targets |
EP3607974A1 (en) * | 2013-03-15 | 2020-02-12 | The Trustees of The University of Pennsylvania | Cancer vaccines and methods of treatment using the same |
EP3524262A1 (en) * | 2013-11-01 | 2019-08-14 | Pfizer Inc | Vectors for expression of prostate-associated antigens |
CN104761644A (zh) * | 2014-01-03 | 2015-07-08 | 百奇生物科技(苏州)有限公司 | 大肠杆菌表达的融合蛋白mbp-mart-1及其制备和应用 |
CN103837688A (zh) * | 2014-03-27 | 2014-06-04 | 吉林农业大学 | 一种检测犬猫弓形虫抗体的间接elisa试剂盒 |
WO2015149010A1 (en) * | 2014-03-28 | 2015-10-01 | University Of Washington Through Its Center For Commercialization | Methods of identifying antigens for vaccines |
US10293035B2 (en) | 2014-03-28 | 2019-05-21 | University Of Washington Through Its Center For Commercialization | Breast and ovarian cancer vaccines |
US9549914B2 (en) | 2014-04-03 | 2017-01-24 | The Johns Hopkins University | Treatment of human cytomegalovirus by modulating Wnt |
SG10201913324PA (en) * | 2014-05-29 | 2020-03-30 | Macrogenics Inc | Tri-specific binding molecules and methods of use thereof |
CN104142401B (zh) * | 2014-07-25 | 2016-04-20 | 北京普恩光德生物科技开发有限公司 | 膀胱肿瘤相关抗原检测试剂盒 |
WO2016128060A1 (en) * | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
CN105067731B (zh) * | 2015-06-05 | 2017-06-16 | 中国农业科学院兰州兽医研究所 | 一种弓形虫感染后血清中生物标记物的筛选方法及筛选出的生物标记物的应用 |
KR20180050321A (ko) | 2015-08-07 | 2018-05-14 | 이미지냅 인코포레이티드 | 분자를 표적화하기 위한 항원 결합 구조체 |
CN105175498A (zh) * | 2015-10-09 | 2015-12-23 | 深圳市康尔诺生物技术有限公司 | 一种宫颈癌相关的热休克蛋白复合物及其应用 |
EP3383427A4 (en) | 2015-12-04 | 2019-11-27 | Mayo Foundation for Medical Education and Research | METHODS AND VACCINES FOR INDUCING IMMUNE RESPONSES OF MULTIPLE DIFFERENT CMH MOLECULES |
BR112018012826A2 (pt) * | 2015-12-23 | 2018-12-04 | Medigene Immunotherapies Gmbh | método para gerar linfócitos, para gerar um tcr e tcr específico para gage-1 |
EP3475446A1 (en) * | 2016-06-27 | 2019-05-01 | Juno Therapeutics, Inc. | Method of identifying peptide epitopes, molecules that bind such epitopes and related uses |
CN110809580A (zh) * | 2017-01-24 | 2020-02-18 | 安贝科思生物制剂公司 | 用于靶向癌症中包含非典型hla-i和新抗原的复合体的方法和组合物 |
WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
WO2018217852A1 (en) * | 2017-05-23 | 2018-11-29 | Gettysburg College | Crispr based tool for characterizing bacterial serovar diversity |
CN112813099A (zh) * | 2019-11-15 | 2021-05-18 | 上海细胞治疗集团有限公司 | 一种在活化的t细胞中具有高活性的启动子 |
WO2024050547A2 (en) * | 2022-09-02 | 2024-03-07 | Hunterian Medicine Llc | Compact bidirectional promoters for gene expression |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439199A (en) * | 1980-02-19 | 1984-03-27 | Alza Corporation | Method for administering immunopotentiator |
US4683199A (en) * | 1983-01-31 | 1987-07-28 | Sloan-Kettering Institute For Cancer Research | Interleukin-2 dependent cytotoxic T-cell clones |
US5168062A (en) * | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US5132213A (en) * | 1986-10-02 | 1992-07-21 | Massachusetts Institute Of Technology | Method for producing proteins and polypeptides using ubiquitin fusions |
US5093242A (en) * | 1986-10-02 | 1992-03-03 | Massachusetts Institute Of Technology | Methods of generating desired amino-terminal residues in proteins |
US5196321A (en) * | 1986-10-02 | 1993-03-23 | Massachusetts Institute Of Technology | Methods for in vitro cleavage of ubiquitin fusion proteins |
US4937190A (en) * | 1987-10-15 | 1990-06-26 | Wisconsin Alumni Research Foundation | Translation enhancer |
US5258294A (en) * | 1988-02-12 | 1993-11-02 | Commonwealth Scientific And Industrial Research Organisation | Bidirectional pox virus promoter element |
US6723832B1 (en) * | 1996-10-03 | 2004-04-20 | Ludwig Institute For Cancer Research | Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
ATE184704T1 (de) | 1989-11-03 | 1999-10-15 | Donald L Morton | Nachweismethode für harnkarzinom-assoziierte antigene |
DE4143467C2 (de) * | 1991-05-17 | 1995-02-09 | Max Planck Gesellschaft | Peptidmotiv und dessen Verwendung |
US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
DE4228458A1 (de) * | 1992-08-27 | 1994-06-01 | Beiersdorf Ag | Multicistronische Expressionseinheiten und deren Verwendung |
US5744316A (en) * | 1992-12-22 | 1998-04-28 | Ludwig Institute For Cancer Research | Isolated, tyrosinase derived peptides and uses thereof |
US5989565A (en) | 1993-01-29 | 1999-11-23 | University Of Pittsburgh | Elution and identification of T cell epitopes from viable cells |
EP0689551B1 (en) * | 1993-03-17 | 2008-02-20 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
US5679647A (en) * | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5478556A (en) * | 1994-02-28 | 1995-12-26 | Elliott; Robert L. | Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colony stimulating factor |
US5874560A (en) * | 1994-04-22 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Melanoma antigens and their use in diagnostic and therapeutic methods |
DE4423392A1 (de) * | 1994-07-04 | 1996-01-11 | Birsner & Grob Biotech Gmbh | Verfahren zur Identifizierung antigener Peptide |
FR2722208B1 (fr) * | 1994-07-05 | 1996-10-04 | Inst Nat Sante Rech Med | Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique |
US5962428A (en) * | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5698396A (en) * | 1995-06-07 | 1997-12-16 | Ludwig Institute For Cancer Research | Method for identifying auto-immunoreactive substances from a subject |
EP0900380B1 (en) * | 1996-04-26 | 2003-07-09 | Rijksuniversiteit te Leiden | Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes |
US6287756B1 (en) * | 1997-05-05 | 2001-09-11 | Ludwig Institute For Cancer Research | Methods for determining presence of cancer in a sample by determining expression of an SSX gene |
US6299295B1 (en) | 1997-07-03 | 2001-10-09 | Matsushita Electric Industrial Co., Ltd. | Ink jet printing head having ink chambers arranged in succession by lamination |
FR2794370B1 (fr) * | 1999-06-03 | 2003-10-17 | Biovector Therapeutics | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
EP1118860A1 (en) * | 2000-01-21 | 2001-07-25 | Rijksuniversiteit te Leiden | Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
US6861234B1 (en) * | 2000-04-28 | 2005-03-01 | Mannkind Corporation | Method of epitope discovery |
US20030215425A1 (en) * | 2001-12-07 | 2003-11-20 | Simard John J. L. | Epitope synchronization in antigen presenting cells |
US20040236514A1 (en) * | 2001-12-13 | 2004-11-25 | Lee Stephen C. | Controlling distribution of epitopes in polypeptide sequences |
-
2001
- 2001-04-27 EP EP10178756A patent/EP2278023A1/en not_active Withdrawn
- 2001-04-27 AU AU2001257410A patent/AU2001257410B8/en not_active Ceased
- 2001-04-27 DK DK01930922.8T patent/DK1276896T3/da active
- 2001-04-27 NZ NZ521715A patent/NZ521715A/en not_active IP Right Cessation
- 2001-04-27 CA CA002405363A patent/CA2405363A1/en not_active Abandoned
- 2001-04-27 JP JP2001579836A patent/JP2003535824A/ja active Pending
- 2001-04-27 WO PCT/US2001/013806 patent/WO2001082963A2/en active Application Filing
- 2001-04-27 DE DE60142615T patent/DE60142615D1/de not_active Expired - Lifetime
- 2001-04-27 EP EP01930922A patent/EP1276896B1/en not_active Expired - Lifetime
- 2001-04-27 EP EP10178766A patent/EP2278024A1/en not_active Withdrawn
- 2001-04-27 EP EP10170170A patent/EP2248910A1/en not_active Withdrawn
- 2001-04-27 AT AT01930922T patent/ATE474931T1/de not_active IP Right Cessation
- 2001-04-27 CN CN01812119A patent/CN1440462A/zh active Pending
- 2001-04-27 AU AU5741001A patent/AU5741001A/xx active Pending
- 2001-04-27 ES ES01930922T patent/ES2347762T3/es not_active Expired - Lifetime
-
2003
- 2003-06-09 HK HK03104029.4A patent/HK1053333A1/xx not_active IP Right Cessation
-
2007
- 2007-03-07 US US11/683,397 patent/US20070269464A1/en not_active Abandoned
-
2010
- 2010-12-14 AU AU2010251790A patent/AU2010251790B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2001082963A3 (en) | 2002-04-11 |
AU2010251790A1 (en) | 2011-01-06 |
US20070269464A1 (en) | 2007-11-22 |
AU2001257410B8 (en) | 2006-12-21 |
EP1276896A2 (en) | 2003-01-22 |
AU2001257410B2 (en) | 2006-08-24 |
JP2003535824A (ja) | 2003-12-02 |
EP2248910A1 (en) | 2010-11-10 |
CA2405363A1 (en) | 2001-11-08 |
AU2010251790B2 (en) | 2013-02-07 |
HK1053333A1 (en) | 2003-10-17 |
EP1276896B1 (en) | 2010-07-21 |
EP2278024A1 (en) | 2011-01-26 |
AU2001257410B9 (en) | 2006-10-05 |
ES2347762T3 (es) | 2010-11-04 |
ATE474931T1 (de) | 2010-08-15 |
NZ521715A (en) | 2008-01-31 |
WO2001082963A2 (en) | 2001-11-08 |
EP2278023A1 (en) | 2011-01-26 |
AU5741001A (en) | 2001-11-12 |
DE60142615D1 (de) | 2010-09-02 |
CN1440462A (zh) | 2003-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1276896T3 (da) | Epitop-synkronisering i antigen-præsenterende celler | |
CY1118629T1 (el) | Εμβολιο ιου ερπητα ζωστηρα | |
NO20015073L (no) | Vaksiner | |
DK1147117T3 (da) | Immunologiske adjuvansforbindelser | |
DK0724432T3 (da) | Fremgangsmåder og præparater til mikroindkapsling af antigener til brug som vacciner | |
DK1216053T3 (da) | Influenzavaccine | |
DE60012042D1 (de) | Entepneumovirus und entsprechendes impfstoff | |
EA200701440A1 (ru) | Композиции для иммунизации против микобактерий | |
DE60115051D1 (de) | Immunologische adjuvans verbindungen | |
WO2003057823A3 (en) | Epitope synchronization in antigen presenting cells | |
DE69720065T2 (de) | Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen | |
OA09037A (en) | Prevention and treatement of retroviral disease. | |
HUP0104125A2 (hu) | Eljárás szárnyasok intradermális immunizálására inaktivált vakcinákkal | |
BR9306187A (pt) | Vacina bacterin-toxóide pasteurella haemolytica tipo a-1 | |
WO2004002412A3 (en) | A method and composition to elicit an effective autologous antitumoral immune response in a patient | |
FR2796282B1 (fr) | Vaccin inactive contre la calicivirose feline | |
WO2005027835A3 (en) | Therapeutic immunization of hiv-infected individuals | |
CY1117601T1 (el) | Ανασυνδυασμενα εμβολια κατα κωπηποδων καλιγιδων (θαλασσιων ψειρων) και αλληλουχιες αντιγονων αυτων | |
Fragoso et al. | A specific vaccine to protect patients with multiple sclerosis from herpes zoster | |
WO2002072622A3 (en) | Vaccine antigens against infection by chlamydia trachomatis | |
AP2000001938A0 (en) | Immune response modulator alpha-2 macroglobulin complex. | |
AR007262A1 (es) | Preparacion de una vacuna no convencional contra la mancha |